IFNAR1 and neoplasm: The upregulation of IFNAR1/2 associated with the BRAFV600E mutation might be linked to the enhanced susceptibility of tumor cells to PDT, potentially rendering BRAFV600E-mutated cells more responsive to stimuli that activate the IFN-1 pathway.